Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect
10.1002/humu.21108
Saved in:
Main Authors: | Tan, E.-K., Refai, F.S., Siddique, M., Yap, K., Ho, P., Fook-Chong, S., Zhao, Y. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110507 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
PINK1 mutations in sporadic early-onset Parkinson's Disease
by: Tan E.-K., et al.
Published: (2018) -
Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons
by: Zhou, Z.D., et al.
Published: (2014) -
Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons
by: Zhou, Zhidong, et al.
Published: (2022) -
ELUCIDATING THE ROLE OF CYTOSOLIC PINK1 IN PARKINSON'S DISEASE
by: CHAN HUI YING
Published: (2021) -
Neurochemistry changes associated with mutations in familial Parkinson's disease
by: Siddique M.M., et al.
Published: (2018)